VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Patients aged greater than 18 years of age         │ Patients aged greater than 18 years of age         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Ability to understand and willingness to comply    │ Ability to understand and willingness to comply    │     100 │
│ with the study protocol                            │ with the study protocol                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Written informed consent                           │ Written informed consent                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients meeting the Rotterdam PCOS workshop       │ Patients meeting the Rotterdam PCOS workshop       │     100 │
│ criteria for polycystic ovary syndrome, defined by │ criteria for polycystic ovary syndrome, defined by │         │
│ oligomenorrhea or amenorrhea and at least one of   │ oligomenorrhea or amenorrhea and at least one of   │         │
│ the following two signs: clinical or biochemical   │ the following two signs: clinical or biochemical   │         │
│ evidence of hyperandrogenism or ultrasound finding │ evidence of hyperandrogenism or ultrasound finding │         │
│ of polycystic appearing ovaries                    │ of polycystic appearing ovaries                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current pregnancy or lactation                     │ Current pregnancy or lactation                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Liver disease or elevated liver enzymes            │ Liver disease or elevated liver enzymes            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Established diagnosis of diabetes mellitus         │ Established diagnosis of diabetes mellitus         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Abnormal serum glucose levels either at fasting or │ Abnormal serum glucose levels either at fasting or │     100 │
│ after the 2-hr oral glucose tolerance test meeting │ after the 2-hr oral glucose tolerance test meeting │         │
│ criteria for the diagnosis of diabetes mellitus    │ criteria for the diagnosis of diabetes mellitus    │         │
│ according to the American Diabetes Association     │ according to the American Diabetes Association     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Insulin sensitizing treatment within 3 months      │ Insulin sensitizing treatment within 3 months      │     100 │
│ prior to or during the eight week study period     │ prior to or during the eight week study period     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Hormonal treatment involving estrogen or           │ Hormonal treatment involving estrogen or           │     100 │
│ progesterone 3 months prior to or during the study │ progesterone 3 months prior to or during the study │         │
│ period, with the exception of medroxyprogesterone  │ period, with the exception of medroxyprogesterone  │         │
│ acetate for withdrawal bleeding                    │ acetate for withdrawal bleeding                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Systemic or inhaled corticosteroids                │ Systemic or inhaled corticosteroids                │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known hypersensitive reaction to cinnamon          │ Known hypersensitive reaction to cinnamon          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with seizure disorders, known             │ Patients with seizure disorders, known             │     100 │
│ cardiovascular disease, or cerebrovascular disease │ cardiovascular disease, or cerebrovascular disease │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body mass index (BMI)range 20-50 (excluding all    │ Body mass index (BMI)range 20-50 (excluding all    │     100 │
│ women with BMI under 20 or over 50)                │ women with BMI under 20 or over 50)                │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                              │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════╪═════════╡
│ Must be FEMALE                    │ Current pregnancy or lactation             │      23 │
├───────────────────────────────────┼────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 38 Years │ Patients aged greater than 18 years of age │      40 │
├───────────────────────────────────┼────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ Patients aged greater than 18 years of age │      43 │
╘═══════════════════════════════════╧════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 88.58823529411765
OverAll Ratio: 92.79411764705883
